IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

TODOERTI, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.315
NA - Nord America 15.250
AS - Asia 12.132
Continente sconosciuto - Info sul continente non disponibili 1.841
SA - Sud America 994
AF - Africa 269
OC - Oceania 62
Totale 52.863
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.683
DE - Germania 10.479
CN - Cina 4.358
GB - Regno Unito 4.286
SG - Singapore 2.921
IT - Italia 2.612
SE - Svezia 1.100
RU - Federazione Russa 1.089
BD - Bangladesh 1.045
HK - Hong Kong 880
VN - Vietnam 767
BR - Brasile 694
FR - Francia 684
IN - India 633
UA - Ucraina 421
CA - Canada 392
NL - Olanda 392
TR - Turchia 374
IE - Irlanda 361
KR - Corea 349
FI - Finlandia 302
EU - Europa 226
JP - Giappone 199
ID - Indonesia 195
CO - Colombia 146
DK - Danimarca 112
PL - Polonia 111
EG - Egitto 85
CI - Costa d'Avorio 66
MX - Messico 63
AR - Argentina 58
AU - Australia 55
IQ - Iraq 55
GR - Grecia 51
MY - Malesia 47
AT - Austria 42
BE - Belgio 42
ES - Italia 37
PH - Filippine 34
ZA - Sudafrica 33
EC - Ecuador 32
CH - Svizzera 28
TW - Taiwan 28
RO - Romania 26
PK - Pakistan 25
UZ - Uzbekistan 24
MA - Marocco 22
IR - Iran 21
VE - Venezuela 21
NO - Norvegia 20
NP - Nepal 20
TH - Thailandia 20
SA - Arabia Saudita 19
CZ - Repubblica Ceca 18
AE - Emirati Arabi Uniti 17
JM - Giamaica 17
PY - Paraguay 16
JO - Giordania 14
TN - Tunisia 14
AL - Albania 13
CL - Cile 13
CR - Costa Rica 13
HN - Honduras 13
TT - Trinidad e Tobago 13
KE - Kenya 11
BG - Bulgaria 10
PT - Portogallo 10
GT - Guatemala 9
HU - Ungheria 9
IL - Israele 9
AZ - Azerbaigian 8
LU - Lussemburgo 8
RS - Serbia 8
SV - El Salvador 8
HR - Croazia 7
LT - Lituania 7
NI - Nicaragua 7
DZ - Algeria 6
KW - Kuwait 6
MD - Moldavia 6
MO - Macao, regione amministrativa speciale della Cina 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
UY - Uruguay 6
BO - Bolivia 5
BY - Bielorussia 5
CW - ???statistics.table.value.countryCode.CW??? 5
CY - Cipro 5
DO - Repubblica Dominicana 5
GE - Georgia 5
QA - Qatar 5
SC - Seychelles 5
AM - Armenia 4
BH - Bahrain 4
BS - Bahamas 4
OM - Oman 4
PR - Porto Rico 4
BB - Barbados 3
EE - Estonia 3
ET - Etiopia 3
Totale 51.168
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 7.824
Southend 3.788
Ashburn 1.703
Singapore 1.617
Beijing 980
Hong Kong 802
Chandler 788
Milan 759
San Jose 732
Hanover 731
Boise 655
Seattle 646
Council Bluffs 615
Wilmington 474
Princeton 463
Fairfield 461
Santa Clara 417
Dallas 394
Dublin 356
Jacksonville 334
Dearborn 326
Los Angeles 321
Woodbridge 288
Houston 287
Nanjing 262
New York 245
Ho Chi Minh City 224
Ann Arbor 222
Bengaluru 222
Shanghai 213
Guangzhou 198
Lauterbourg 197
Mountain View 197
Cambridge 194
Redmond 184
Buffalo 177
Hanoi 173
Toronto 170
Somerville 162
Boardman 156
Hefei 145
Des Moines 141
Moscow 140
Andover 135
Jakarta 132
Serra 131
Sakarya 121
Bogotá 119
Helsinki 118
Jinan 111
Rome 111
Tokyo 107
Phoenix 104
Berlin 100
Shenyang 93
Nanchang 91
Naples 85
Columbus 83
Warsaw 83
Tianjin 82
Changsha 79
São Paulo 78
Redwood City 69
The Dalles 67
Abidjan 66
Chicago 66
Hangzhou 65
Cangzhou 64
Hebei 60
Turin 60
Wuhan 60
Zhengzhou 60
London 57
Seoul 57
Eitensheim 55
Saint Petersburg 54
San Diego 52
Matera 51
Athens 47
Brescia 47
Munich 47
Atlanta 45
Chengdu 44
Fuzhou 43
Hamburg 39
Montreal 38
Pisa 38
Bitonto 37
Boston 37
San Francisco 37
Shenzhen 37
Washington 37
Grafing 36
Roxbury 36
Da Nang 35
Dong Ket 35
Nuremberg 35
Odernheim 35
Orofino 35
Silver Spring 34
Totale 33.163
Salva come PNG Salva come JPEG
Nome #
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide 1.026
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 813
Pathogenicity of in-vivo generated intestinal Th17 lymphocytes is IFNγ dependent 566
Clinical-biological characterization of variant B chronic lymphocytic leukemia, characterized by a mantle cell lymphoma-like immunophenotype, t(11;14)(q13;q32) negative 542
COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death 541
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 493
Canonical and non canonical Hedgehog pathway in the pathogenesis of multiple myeloma 491
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 483
A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes 454
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 450
Amino acid depletion triggered by L-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death 425
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 417
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma 416
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 415
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing 395
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns 392
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma 389
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 368
The ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNA 366
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome 360
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 358
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 353
Notch signaling drives multiple myeloma induced osteoclastogenesis 352
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche 351
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 347
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma 347
Analisi del numero di copie e sequenza del DNA in campioni sequenziali di melanoma alla diagnosi e recidiva=DNA copy number and whole-exome sequencing analyses in sequential myeloma samples at diagnosis and relapse 346
The expression pattern of small nucleolar and small cajal body-specific RNAS characterizes distinct molecular subtypes of multiple myeloma 341
Disentangling the microRNA regulatory milieu in multiple myeloma : integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 340
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification 340
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma 339
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 334
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 329
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line 321
Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature 315
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening 311
Bone microenvironment cells reveal a different gene expression profiling in multiple myeloma patients as compared to healthy subjects : potential relationship with the bone status 310
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 308
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia 307
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma 306
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma : an integrated genomics approach reveals a wide gene dosage effect 302
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia 302
The role of notch pathway in multiple myeloma progression toward IL-6 independence 302
Genome-wide approach identify recurrent 8p21.2 loss in more aggressive form of primary plasma-cell leukemia 299
Analysis of CD44 expression in monoclonal gammopathies : correlation between gene expression level and flow cytometry findings 297
Multiple myeloma-associated drug resistance : targeting the Notch pathway 296
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 295
Notch targeting prevents multiple myeloma associated osteoclastogenesis 294
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles 292
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma 291
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome 289
Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression 288
Jagged-induced notch signaling promotes endogenous and bone marrow-mediated drug resistance in multiple myeloma 287
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 283
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological molecular characterization by a genomic integrative analisys 283
Bone microenvironment cells reveals a different gene expression profyling in multiple myeloma patients in relation to the bone status 282
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma 282
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma 282
Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine 281
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma 281
Notch pathway promotes multiple myeloma cell IL-6 independence 277
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems? 276
In silico characterization of miRNA and long non-coding RNA interplay in multiple myeloma 275
Molecular definition of 17P11-P12 amplification in multiple myeloma 274
Dioxin exposure of human CD34(+) hemopoietic cells induces gene expression modulation that recapitulates its in vivo clinical and biological effects 273
The Notch pathway controls multiple myeloma crosstalk with the osteoclastogenic niche 268
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys 260
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma 254
Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma 253
Jagged-directed therapy in multiple myeloma: a new approach to interrupt the crosstalk between the tumor cell and the bone marrow microenvironment 253
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment 253
Biological and molecular characterization by integrative genomics approach of CMA-03/06, a newly established interleukin-6 independent variant of the CMA-03 human myeloma cell line 252
ESTABLISHMENT OF AN INTERLEUKIN-6 INDEPENDENT VARIANT (CMA-03/06) OF THE HUMAN MYELOMA CELL LINE CMA-03 : BIOLOGICAL AND MOLECULAR CHARACTERIZATION BY A GENOMIC INTEGRATIVE ANALYSIS 252
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance 252
Genome-wide DNA copy number analysis by SNP arrays of B-cell chronic lymphocytic leukemia reveals the presence of novel molecular lesions 251
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia 250
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys 248
Dissecting the biological relevance and clinical impact of lncrna miat in multiple myeloma 248
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 246
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs 246
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 244
Integrative genomic analysis of primary plasma cell leukemia revealed strong gene and microrna dosage effect 244
Are the myeloma bone microevironment cells tumoral or not? 243
In vitro anti-leukaemia activity of sphingosine kinase inhibitor 243
Understanding the interaction of human cancer cells with the surrounding microenvironment: the new challenge in modern oncology 243
A retained transcriptomic profile characterizes CD138+ cells in the short time progression from smoldering to active multiple myeloma 241
Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines 240
Global methylation patterns in primary plasma cell leukemia 240
A patient-adapted pilot study of lenalidomide in combination with low dose dexamethasone (LD) as initial therapy for a primary plasma cell leukemia (PPCL) 239
Transcriptional features of 1Q in multiple myeloma 238
Integrative genomics in molecular analysisn in multiple myeloma 238
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 238
Notch pathway and Inteleukin-6 cooperate to support multiple myeloma cell proliferation 237
The immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and rankl/opg ratio in myeloma microenvironment targeting the expression of adhesion molecules 236
Notch pathway and Interleukin-6 cooperate and support multiple myeloma cell growth 236
Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines 235
Gene expression profiling of multiple myeloma : implications for a molecular classification of the disease 235
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study 235
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 234
Integrative genomic approach based on SNP-array and gene expression profiling reveals the presence of molecularly distinct subgroups in early stage b-cell chronic lymphocytic leukemia 232
Totale 32.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.119
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.075 0 0 0 264 372 295 372 262 459 301 212 538
2022/20233.207 454 293 273 298 377 604 89 192 317 72 164 74
2023/20247.225 80 161 112 177 614 300 1.099 999 493 972 1.059 1.159
2024/20257.242 1.019 977 852 816 323 222 197 526 306 462 418 1.124
2025/202610.604 971 680 927 849 933 675 1.185 498 1.055 653 1.281 897
2026/20272.883 785 722 816 560 0 0 0 0 0 0 0 0
Totale 52.863